Meritage Pharma

About:

Meritage Pharma develops prescription products for the treatment of gastrointestinal and atopic diseases.

Top Investors: MPM Capital, Domain Associates, The Vertical Group, Latterell Venture Partners

Description:

Meritage Pharma, Inc. develops prescription products for the treatment of gastrointestinal and atopic diseases. It offers budesonide, an active pharmaceutical ingredient and a glucocorticoid steroid for products that treat pediatric asthma, allergic rhinitis, and Crohn’s disease; and oral budesonide suspension, an oral formulation of budesonide for the potential treatment of adolescents and young adults with eosinophilic esophagitis, an allergic inflammation of the gastrointestinal tract. Meritage Pharma, Inc. was founded in 2008 and is based in San Diego, California.

Total Funding Amount:

$59M

Headquarters Location:

San Diego, California, United States

Founded Date:

2008-01-01

Contact Email:

information(AT)meritagepharma.com

Founders:

Malcolm R. Hill, Ranjan Dohil

Number of Employees:

11-50

Last Funding Date:

2011-11-16

IPO Status:

Private

Industries: